EA028171B1 - Способ получения высокочистой калиевой соли азилсартана медоксомила - Google Patents

Способ получения высокочистой калиевой соли азилсартана медоксомила Download PDF

Info

Publication number
EA028171B1
EA028171B1 EA201590657A EA201590657A EA028171B1 EA 028171 B1 EA028171 B1 EA 028171B1 EA 201590657 A EA201590657 A EA 201590657A EA 201590657 A EA201590657 A EA 201590657A EA 028171 B1 EA028171 B1 EA 028171B1
Authority
EA
Eurasian Patent Office
Prior art keywords
azilsartan medoxomil
solvate
dimethylacetamide
potassium salt
methylpyrrolidone
Prior art date
Application number
EA201590657A
Other languages
English (en)
Russian (ru)
Other versions
EA201590657A1 (ru
Inventor
Ян Стах
Радим Крулис
Йосеф Церны
Лудек Ридван
Ондрей Даммер
Лукас Крейцик
Станислав Радл
Original Assignee
Зентива К.С.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Зентива К.С. filed Critical Зентива К.С.
Publication of EA201590657A1 publication Critical patent/EA201590657A1/ru
Publication of EA028171B1 publication Critical patent/EA028171B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Epidemiology (AREA)
EA201590657A 2012-09-26 2013-09-25 Способ получения высокочистой калиевой соли азилсартана медоксомила EA028171B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ2012-663A CZ305318B6 (cs) 2012-09-26 2012-09-26 Způsob přípravy vysoce čisté draselné soli azilsartanu medoxomilu
PCT/CZ2013/000114 WO2014048404A1 (en) 2012-09-26 2013-09-25 A method of preparing a highly pure potassium salt of azilsartan medoxomil

Publications (2)

Publication Number Publication Date
EA201590657A1 EA201590657A1 (ru) 2015-08-31
EA028171B1 true EA028171B1 (ru) 2017-10-31

Family

ID=66624776

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201590657A EA028171B1 (ru) 2012-09-26 2013-09-25 Способ получения высокочистой калиевой соли азилсартана медоксомила

Country Status (12)

Country Link
EP (1) EP2900662A1 (cs)
JP (1) JP2015532267A (cs)
KR (1) KR20150060733A (cs)
CN (1) CN104662019A (cs)
BR (1) BR112015006572A2 (cs)
CZ (1) CZ305318B6 (cs)
EA (1) EA028171B1 (cs)
HK (1) HK1205505A1 (cs)
IL (1) IL237884A0 (cs)
MX (1) MX2015003209A (cs)
UA (1) UA113668C2 (cs)
WO (1) WO2014048404A1 (cs)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ2014702A3 (cs) * 2014-10-15 2016-04-27 Zentiva, K.S. Způsob přípravy vysoce čistého azilsartanu
CN105753854A (zh) * 2014-12-16 2016-07-13 重庆朗天制药有限公司 一种阿齐沙坦酯钾盐的新制备方法
WO2017131218A1 (ja) * 2016-01-28 2017-08-03 株式会社トクヤマ アジルサルタン及びその製造方法
CN108727356A (zh) * 2018-06-28 2018-11-02 江苏新瑞药业有限公司 一种奥美沙坦酯碱金属盐的合成方法

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050187269A1 (en) * 2004-02-25 2005-08-25 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
WO2013042067A1 (en) * 2011-09-20 2013-03-28 Ranbaxy Laboratories Limited Process for the preparation of potassium salt of azilsartan medoxomil
WO2013104342A1 (en) * 2012-01-14 2013-07-18 Sunshine Lake Pharma Co., Ltd. Crystalline forms of azilsartan medoxomil potassium and preparation and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012090043A1 (en) * 2010-12-29 2012-07-05 Jubilant Life Sciences Limited Novel solid state forms of azilsartan medoxomil and preparation thereof
WO2012107814A1 (en) * 2011-02-08 2012-08-16 Jubilant Life Sciences Limited An improved process for the preparation of azilsartan medoxomil
CZ2012274A3 (cs) * 2012-04-19 2013-10-30 Zentiva, K.S. Zpusob prípravy vysoce cisté draselné soli azilsartanu medoxomilu

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050187269A1 (en) * 2004-02-25 2005-08-25 Takeda Pharmaceutical Company Limited Benzimidazole derivative and use thereof
WO2013042067A1 (en) * 2011-09-20 2013-03-28 Ranbaxy Laboratories Limited Process for the preparation of potassium salt of azilsartan medoxomil
WO2013104342A1 (en) * 2012-01-14 2013-07-18 Sunshine Lake Pharma Co., Ltd. Crystalline forms of azilsartan medoxomil potassium and preparation and uses thereof

Also Published As

Publication number Publication date
CZ305318B6 (cs) 2015-07-29
CN104662019A (zh) 2015-05-27
EA201590657A1 (ru) 2015-08-31
CZ2012663A3 (cs) 2014-04-02
IL237884A0 (en) 2015-05-31
KR20150060733A (ko) 2015-06-03
JP2015532267A (ja) 2015-11-09
UA113668C2 (uk) 2017-02-27
BR112015006572A2 (pt) 2017-07-04
EP2900662A1 (en) 2015-08-05
HK1205505A1 (en) 2015-12-18
MX2015003209A (es) 2015-07-14
WO2014048404A1 (en) 2014-04-03

Similar Documents

Publication Publication Date Title
EP3190102B1 (en) CRYSTAL OF (S)-1-(2-HYDROXYETHYL)-4-METHYL-N- [4-(METHYLSULFONYL)PHENYL]-5-[2-(TRIFLUOROMETHYL)& xA;PHENYL]- 1H-PYRROLE-3-CARBOXAMIDE
KR20120033357A (ko) 다사티닙 다형체 및 이의 제조 방법
WO2017040872A1 (en) Solid state forms of selexipag
EA020067B1 (ru) Полиморфная форма iii n-[2-(диэтиламино)этил]-5-[(5-фтор-1,2-дигидро-2-оксо-3н-индол-3-илиден)метил]-2,4-диметил-1н-пиррол-3-карбоксамида и способ её получения
EA028171B1 (ru) Способ получения высокочистой калиевой соли азилсартана медоксомила
US20160145269A1 (en) Dolutegravir salts
US9624207B2 (en) Polymorphs of azilsartan medoxomil
US12116374B2 (en) Solid forms of 3-(5-Fluorobenzofuran-3-yl)-4-(5-methyl-5H-[1,3]dioxolo[4,5-f]indol-7-yl)pyrrole-2,5-dione
WO2009074862A1 (en) Polymorphic forms of a 3-pyrrole substituted 2-indolinone
WO2016172333A1 (en) A solid state form of perampanel
WO2013124748A1 (en) Novel polymorphs of azilsartan medoxomil potassium
WO2013156005A1 (en) Method of preparing potassium salt of azilsartan medoxomil of high purity
WO2012125993A1 (en) Solid state forms of rilpivirine base, and rilipivirine salts
WO2014173377A2 (en) New crystalline forms of apixaban and a method of their preparation
WO2010131118A2 (en) Polymorphs of etravirine and processes for preparation thereof
JP2018076258A (ja) アジルサルタンアルキルエステル、アジルサルタンメチルエステルの製造方法、及びアジルサルタンの製造方法
JP2017535533A (ja) 高純度のアジルサルタンを調製するための方法
JP2018197206A (ja) アジルサルタン合成中間体の製造方法
US20150291574A1 (en) Novel polymorphs of azilsartan
WO2013181384A1 (en) Solid state forms of aleglitazar sodium

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG TJ TM RU